156 related articles for article (PubMed ID: 11112465)
1. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.
Petersen E; Gineitis A; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):457-61. PubMed ID: 11112465
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture.
Petersen E; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):153-7. PubMed ID: 11863333
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Papalambros E; Sigala F; Georgopoulos S; Menekakos C; Giatromanolaki A; Bastounis E; Sivridis E
Int J Mol Med; 2003 Dec; 12(6):965-8. PubMed ID: 14612975
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Schwalbe EC; Jones JL; Furness PN; Bell PR; Thompson MM
Circulation; 2006 Jan; 113(3):438-45. PubMed ID: 16432074
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of tensile strength and matrix metalloproteinase activity in the wall of abdominal aortic aneurysms.
Vallabhaneni SR; Gilling-Smith GL; How TV; Carter SD; Brennan JA; Harris PL
J Endovasc Ther; 2004 Aug; 11(4):494-502. PubMed ID: 15298501
[TBL] [Abstract][Full Text] [Related]
6. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
7. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection.
Manabe T; Imoto K; Uchida K; Doi C; Takanashi Y
Surg Today; 2004; 34(3):220-5. PubMed ID: 14999533
[TBL] [Abstract][Full Text] [Related]
8. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall.
Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM
Br J Surg; 2000 Oct; 87(10):1391-400. PubMed ID: 11044166
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K
World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic abdominal aortic aneurysms show histological signs of progression: a quantitative histochemical analysis.
Eberlová L; Tonar Z; Witter K; Křížková V; Nedorost L; Korabečná M; Tolinger P; Kočová J; Boudová L; Třeška V; Houdek K; Moláček J; Vrzalová J; Pešta M; Topolčan O; Valenta J
Pathobiology; 2013; 80(1):11-23. PubMed ID: 22797551
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
Evans J; Powell JT; Schwalbe E; Loftus IM; Thompson MM
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):302-3. PubMed ID: 17574455
[TBL] [Abstract][Full Text] [Related]
14. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm.
Kazi M; Zhu C; Roy J; Paulsson-Berne G; Hamsten A; Swedenborg J; Hedin U; Eriksson P
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1341-6. PubMed ID: 15845912
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.
Grzela T; Brawura-Biskupski-Samaha R; Jelenska MM; Szmidt J
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):159-61. PubMed ID: 17964826
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.
Eliason JL; Hannawa KK; Ailawadi G; Sinha I; Ford JW; Deogracias MP; Roelofs KJ; Woodrum DT; Ennis TL; Henke PK; Stanley JC; Thompson RW; Upchurch GR
Circulation; 2005 Jul; 112(2):232-40. PubMed ID: 16009808
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Boyum J; Fellinger EK; Schmoker JD; Trombley L; McPartland K; Ittleman FP; Howard AB
J Thorac Cardiovasc Surg; 2004 Mar; 127(3):686-91. PubMed ID: 15001896
[TBL] [Abstract][Full Text] [Related]
18. Thrombus versus wall biological activities in experimental aortic aneurysms.
Coutard M; Touat Z; Houard X; Leclercq A; Michel JB
J Vasc Res; 2010; 47(4):355-66. PubMed ID: 20016209
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease.
Koole D; Hurks R; Schoneveld A; Vink A; Golledge J; Moran CS; de Kleijn DP; van Herwaarden JA; de Vries JP; Laman JD; Huizinga R; Pasterkamp G; Moll FL
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1497-504. PubMed ID: 22516062
[TBL] [Abstract][Full Text] [Related]
20. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms.
Abisi S; Burnand KG; Humphries J; Waltham M; Taylor P; Smith A
Br J Surg; 2008 Mar; 95(3):333-7. PubMed ID: 17968978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
